Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1258013

HIV Pre-Exposure Prophylaxis (PrEP) and STIs


Zekan, Šime
HIV Pre-Exposure Prophylaxis (PrEP) and STIs // 6th International Symposium Sexually Transmitted Infections - New Horizons
Brijuni, Hrvatska, 2022. str. 67-67 (predavanje, domaća recenzija, sažetak, znanstveni)


CROSBI ID: 1258013 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
HIV Pre-Exposure Prophylaxis (PrEP) and STIs

Autori
Zekan, Šime

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Skup
6th International Symposium Sexually Transmitted Infections - New Horizons

Mjesto i datum
Brijuni, Hrvatska, 16.09.2022. - 18.09.2022

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Domaća recenzija

Ključne riječi
HIV. ; PrEP ; STI

Sažetak
HIV pre-exposure prophylaxis (PrEP) is a medical intervention with the antiretroviral drug(s) used as prophylaxis in order to achieve high level of protection against HIV infection. It does not protect against other sexually transmitted infections (STI) though. Therefore, PrEP should be supervised by a doctor, experienced with STI and antiretroviral drugs. Documented negative HIV test (4th generation HIV test or even molecular test) is obligatory prior to starting PrEP. In Europe PrEP is recommended in men who have sex with men (MSM) and transgender individuals but may be considered in heterosexual women and men who are inconsistent in their use of condoms and have multiple sexual partners where some of whom are likely to have HIV infection. On the other hand, in Sub-Saharan Africa main users of PrEP are young women. Scaling Up PrEP Access in certain urban areas (San Francisco, Seattle, London, Sydney) where epidemics were driven MSM has resulted in population level reductions in new HIV infections. Higher rates of STIs among PrEP users have been noticed but it is still unclear if this is driven by taking more risk being on PrEP or being tested more often. PrEP users, according to current guidelines, should be seen every 3 months for HIV testing, STI testing and prescribing PrEP regimen. With such close monitoring many asymptomatic or neglected STIs could be diagnosed and treated resulting in better STI control on a large scale in certain population. To achieve its full potential PrEP should be combined with other prevention methods and it should not be seen just as a HIV prevention tool but also as an excellent STI surveillance method.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb,
Klinika za infektivne bolesti "Dr Fran Mihaljević"

Profili:

Avatar Url Šime Zekan (autor)


Citiraj ovu publikaciju:

Zekan, Šime
HIV Pre-Exposure Prophylaxis (PrEP) and STIs // 6th International Symposium Sexually Transmitted Infections - New Horizons
Brijuni, Hrvatska, 2022. str. 67-67 (predavanje, domaća recenzija, sažetak, znanstveni)
Zekan, Š. (2022) HIV Pre-Exposure Prophylaxis (PrEP) and STIs. U: 6th International Symposium Sexually Transmitted Infections - New Horizons.
@article{article, author = {Zekan, \v{S}ime}, year = {2022}, pages = {67-67}, keywords = {HIV., PrEP, STI}, title = {HIV Pre-Exposure Prophylaxis (PrEP) and STIs}, keyword = {HIV., PrEP, STI}, publisherplace = {Brijuni, Hrvatska} }
@article{article, author = {Zekan, \v{S}ime}, year = {2022}, pages = {67-67}, keywords = {HIV., PrEP, STI}, title = {HIV Pre-Exposure Prophylaxis (PrEP) and STIs}, keyword = {HIV., PrEP, STI}, publisherplace = {Brijuni, Hrvatska} }




Contrast
Increase Font
Decrease Font
Dyslexic Font